The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 1,801–2,000 of 3,517
Steiger, J. L., Bandyopadhyay, S., Farb, D. H., & Russek, S. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1200-04.2004 · Cited by 120
Thyroid and adrenal axis in major depression: a controlled study in outpatients
Brouwer, J. P., Appelhof, B. C., Hoogendijk, W. J. G., Huyser, J., Endert, E., Zuketto, C., Schene, A. H., Tijssen, J. G. P., van Dyck, R., Wiersinga, W. M., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01828 · Cited by 120
Stevens, T. R., Krueger, S. R., Fitzsimonds, R. M., & Picciotto, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-10093.2003 · Cited by 119
Molecular neurobiology and pharmacology of the Vasopressin/Oxytocin receptor family
Burbach, J. P. H., Burbach, H., Adan, R. A. H., Lolait, S. J., van Leeuwen, F. W., Mezey, É., Palkovits, M., & Barberis, C. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071318 · Cited by 119
Nitric oxide modulates the release of serotonin in the rat hypothalamus
Kaehler, S. T., Singewald, N., Sinner, C., & Philippu, A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01599-1 · Cited by 119
Modafinil affects mood, but not cognitive function, in healthy young volunteers
Randall, D. C., Shneerson, J. M., Plaha, K. K., & File, S. E. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.456 · Cited by 119
Schultheiss, D., Müller, S., Nager, W., Stief, C. G., Schlote, N., Udo Jonas, A., Asvestis, C., Johannes, S., & Münte, T. (2001) · World Journal of Urology · doi:10.1007/pl00007092 · Cited by 119
Reversal and consolidation of activity-induced synaptic modifications
Zhou, Q., & Poo, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.006 · Cited by 119
Millan, M. J., Dekeyne, A., Papp, M., Rochelle, C. D. L., MacSweeny, C., Péglion, J.-L., & Brocco, M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29416-7 · Cited by 119
Self-citationActivation of Metabotropic Glutamate Receptor 1 Accelerates NMDA Receptor Trafficking
Lan, J.-Y., Skeberdis, V. A., Jover, T., Zheng, X., Bennett, M. V. L., & Zukin, R. S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06058.2001 · Cited by 118
Biological Basis of Emotions: Brain Systems and Brain Development
Chugani, H. T. (1998) · PEDIATRICS · doi:10.1542/peds.102.se1.1225 · Cited by 118
Cardiovascular Profile of Duloxetine, a Dual Reuptake Inhibitor of Serotonin and Norepinephrine
Thase, M. E., Trân, P. V., Wiltse, C. G., Pangallo, B. A., Mallinckrodt, C. H., & Detke, M. J. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155815.44338.95 · Cited by 118
Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice
Kelley, S. P., Bratt, A. M., & Hodge, C. W. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02960-6 · Cited by 118
Effects of GABA agonists on body temperature regulation in GABAB(1)−/− mice
Quéva, C., Bremner‐Danielsen, M., Edlund, A., Ekstrand, A. J., Elg, S., Erickson, S., Johansson, T., Lehmann, A., & Mattsson, J. P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705447 · Cited by 118
The neuroanatomical basis of anxiety
Pratt, J. A. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90014-q · Cited by 118
Heilig, M. A., Wahlestedt, C., Ekman, R., & Widerlöv, E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90182-3 · Cited by 118
Shekhar, A., & Keim, S. R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00215-4 · Cited by 118
The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 118
Mammalian Mutation Pressure, Synonymous Codon Choice, and mRNA Degradation
Duan, J., & Antezana, M. A. (2003) · Journal of Molecular Evolution · doi:10.1007/s00239-003-2519-1 · Cited by 118
Suicidality in schizophrenia: A review of the evidence for risk factors and treatment options
Meltzer, H. Y. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-996-0047-6 · Cited by 118
Transgenic Studies of Pain and Analgesia: Mutation or Background Genotype?
Lariviere, W. R., Chesler, E. J., & Mogil, J. S. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29558-6 · Cited by 118
Executive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression
Alexopoulos, G. S., Kiosses, D. N., Murphy, C., & Heo, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300557 · Cited by 117
The relationship between interpersonal sensitivity, anxiety disorders and major depression
Wilhelm, K. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00069-1 · Cited by 117
Effects of nicotine and mecamylamine on rat dorsal raphe neurons
Mihailescu, S., Palomero-Rivero, M., Meade-Huerta, P., Maza-Flores, A., & Drucker-Colı́n, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00658-x · Cited by 117
Hampson, R. E., Rogers, G. A., LYNCH, G. S., & Deadwyler, S. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02748.1998 · Cited by 117
Yau, J. L. W., Noble, J., Hibberd, C. J., Rowe, W. B., Meaney, M. J., Morris, R., & Seckl, J. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01436.2002 · Cited by 117
Stein, M. B., Pollack, M. H., Bystritsky, A., Kelsey, J. E., & Mangano, R. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1957-9 · Cited by 117
Functional neuroimaging of cognition impaired by a classical antihistamine, d‐chlorpheniramine
Okamura, N., Yanai, K., Higuchi, M., Sakai, J., Iwata, R., Ido, T., Sasaki, H., Watanabe, T., & Itoh, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702994 · Cited by 117
Béïque, J.-C., Lavoie, N., de Montigny, C., & Debonnel, G. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00241-6 · Cited by 117
Overstreet, D. H., Commissaris, R. C., Garza, R. D. L., File, S. E., Knapp, D. J., & Seiden, L. S. (2003) · Stress · doi:10.1080/1025389031000111311 · Cited by 117
Daniels, D. J., Kulkarni, A. A., Xie, Z., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034234f · Cited by 117
Husum, H., Mikkelsen, J. D., Hogg, S., Mathé, A. A., & Mørk, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00009-5 · Cited by 117
Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166)
Romach, M. K., Glue, P., Kampman, K. M., Kaplan, H. L., Somer, G. R., Poole, S. A., Clarke, L., Coffin, V. L., Cornish, J., O’Brien, C. P., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1101 · Cited by 117
Waldinger, M. D., Zwinderman, A. H., & Olivier, B. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00007 · Cited by 117
Fernández‐Guasti, A., Escalante, A., Ahlénius, S., Hillegaart, V., & Larsson, K. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90662-n · Cited by 117
Liebowitz, M. R., Stein, M. B., Tancer, M. E., Carpenter, D. J., Oakes, R., & Pitts, C. D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0113 · Cited by 117
Koch, S., Hemrick-Luecke, S. K., Thompson, L., Evans, D. C., Threlkeld, P. G., Nelson, D. L., Perry, K. W., & Bymaster, F. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00268-5 · Cited by 117
Matsuno, K., Kobayashi, T., Tanaka, M. K., & Mita, S. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00497-9 · Cited by 117
Chaki, S., Hirota, S., Funakoshi, T., Suzuki, Y., Suetake, S., Okubo, T., Ishii, T., Nakazato, A., & Okuyama, S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044826 · Cited by 117
Kotera, J., Fujishige, K., & Omori, K. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800512 · Cited by 117
Pandey, G. N., & Dwivedi, Y. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004936 · Cited by 117
Corticotropin-releasing hormone modulators and depression.
Holsboer, F. (2003) · PubMed · Cited by 116
Invernizzi, R. W., & Garattini, S. K. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.026 · Cited by 116
Turcotte, J., Debonnel, G., de Montigny, C., Hébert, C., & Blier, P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00220-7 · Cited by 116
Smith, J. W., Fetsko, L. A., Xu, R., & Wang, Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00257-9 · Cited by 116
Caberlotto, L., Fuxé, K., Overstreet, D. H., Gerrard, P. A., & Hurd, Y. L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00137-5 · Cited by 116
Jenck, F., Moreau, J.-L., Mutel, V., Martin, J. R., & Haefely, W. E. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90453-o · Cited by 116
Hudson, J. I., Wohlreich, M. M., Kajdasz, D. K., Mallinckrodt, C. H., Watkin, J. G., & Martynov, O. V. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.696 · Cited by 116
Identification and Differential Vulnerability of a Neural Network in Sleep Deprivation
Bell‐McGinty, S., Habeck, C., Hilton, H. J., Rakitin, B., Scarmeas, N., Zarahn, E., Flynn, J., DeLaPaz, R., Basner, R., & Stern, Y. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh011 · Cited by 116
Davis, C. J., Harding, J. W., & Wright, J. W. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02508-3 · Cited by 115
Antidepressant drug selection: criteria and options.
Preskorn, S. (1994) · PubMed · Cited by 115
Protein kinase C isoforms as therapeutic targets in nervous system disease states
Battaini, F. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0893 · Cited by 115
DeBattista, C., Posener, J. A., Kalehzan, B. M., & Schatzberg, A. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1334 · Cited by 115
Kole, M. H. P., Fuchs, E., Ziemann, U., Paulus, W., & Ebert, U. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01257-3 · Cited by 115
Engber, T. M., Koury, E. J., Dennis, S. A., Miller, M. S., Contreras, P. C., & Bhat, R. V. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00962-2 · Cited by 115
Therapeutic brain concentration of the NMDA receptor antagonist amantadine
Kornhuber, J., Quack, G., Danysz, W., Jellinger, K. A., Danielczyk, W., Gsell, W., & Riederer, P. F. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00056-c · Cited by 115
The Human Dopamine Transporter Forms a Tetramer in the Plasma Membrane
Hastrup, H., Sen, N., & Javitch, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300349200 · Cited by 115
Evidence that serotonin affects female sexual functioning via peripheral mechanisms
Frohlich, P. F., & Meston, C. M. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00344-9 · Cited by 115
Emergence of complex dynamics in a simple model of signaling networks
Amaral, L. A. N., Díaz-Guilera, A., Moreira, A. A., Goldberger, A. L., & Lipsitz, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404843101 · Cited by 115
Ohnishi, T., Hayashi, T., Okabe, S., Nonaka, I., Matsuda, H., Iida, H., Imabayashi, E., Watabe, H., Miyake, Y., Ogawa, M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.016 · Cited by 114
Hetero-oligomerization between GABAA and GABAB Receptors Regulates GABAB Receptor Trafficking
Balasubramanian, S., Teissére, J. A., Raju, D. V., & Hall, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313470200 · Cited by 114
Fairfax, B. P., Pitcher, J. A., Scott, M. G. H., Calver, A. R., Pangalos, M. N., Moss, S. J., & Couve, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311389200 · Cited by 114
Biological networks and analysis of experimental data in drug discovery
Nikolsky, Y., Nikolskaya, T., & Bugrim, A. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03420-3 · Cited by 114
Melatonin analogues as agonists and antagonists in the circadian system and other brain areas
Ying, S.-W., Rusak, B., Delagrange, P., Mocaër, E., Renard, P., & Guardiola-Lemaître, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00684-2 · Cited by 114
5-HT3 receptor antagonists and anxiety; a preclinical and clinical review
Olivier, B., van Wijngaarden, I., & Soudijn, W. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00065-6 · Cited by 114
Linden, A.-M., Greene, S. J., Bergeron, M., & Schoepp, D. D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300321 · Cited by 114
Labbate, L. A., Croft, H. A., & Oleshansky, M. A. (2003) · PubMed · Cited by 113
Nelson, D. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482606 · Cited by 113
Shirayama, Y., Mitsushio, H., Takashima, M., Ichikawa, H., & Takahashi, K. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00812-8 · Cited by 113
Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?
Dourish, C. T. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00212.x · Cited by 113
Melanin-concentrating hormone (MCH) modifies memory retention in rats ☆
Monzon, M. E., de Souza, M. M., Izquierdo, L. A., Izquierdo, I., Barros, D. M., & de Barioglio, S. R. (1999) · Peptides · doi:10.1016/s0196-9781(99)00164-3 · Cited by 113
Redman, J., Brown, M., Lemaître, B. J., Delagrange, P., & Armstrong, S. M. (1995) · Psychopharmacology · doi:10.1007/bf02245938 · Cited by 113
Combining Antidepressants for Treatment-Resistant Depression
Lam, R. W. M., Wan, D. D. C., Cohen, N. L., & Kennedy, S. H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0805 · Cited by 113
Effects of diazepam on circadian phase advances and delays
Ralph, M. R., & Menaker, M. (1986) · Brain Research · doi:10.1016/0006-8993(86)91154-6 · Cited by 113
Generalized Anxiety Disorder in Patients With Major Depression: Is DSM-IV’s Hierarchy Correct?
Zimmerman, M. A., & Chelminski, I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.504 · Cited by 113
Stemmelin, J., Lukovic, L., Salome, N., & Griebel, G. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300562 · Cited by 112
Coronas, V., Bantubungi, K., Fombonne, J., Krantic, S. M., Schiffmann, S. N., & Roger, M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02823.x · Cited by 112
Licht, R. W., & Qvitzau, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-0999-0 · Cited by 112
Regulation of organic cation transport
Ciarimboli, G., & Schlatter, E. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1355-5 · Cited by 112
Lee, K.-H., Kim, M. Y., Kim, D.-H., & Lee, Y. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000026404.08779.43 · Cited by 112
Peptides that fine-tune the serotonin system
Valentino, R. J., & Commons, K. G. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.09.005 · Cited by 112
van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., & Kahn, R. (1996) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00038-7 · Cited by 112
Alves, S. H. D. S., Pinheiro, G. D. A., Motta, V., Landeira-Fernández, J., & Cruz, A. P. D. M. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200402000-00005 · Cited by 112
Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action
Krahl, S. E., Senanayake, S. S., Pekary, A. E., & Sattin, A. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.11.005 · Cited by 112
Patterns and processes in the early evolution of the tetrapod ear
Clack, J. A. (2002) · Journal of Neurobiology · doi:10.1002/neu.10129 · Cited by 112
Retraction of an Interpretation
Zhang, L., Lopez, P., Tian, H., Yu, W., & Ho, D. D. (2004) · Science · doi:10.1126/science.303.5657.467b · Cited by 112
Juckel, G., Mendlin, A., & Jacobs, B. L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00097-9 · Cited by 112
Lithium Augmentation of Nortriptyline for Subjects Resistant to Multiple Antidepressants
Nierenberg, A. A., Papakostas, G. I., Petersen, T., Montoya, H. D., Worthington, J. J., Tedlow, J. R., Alpert, J. E., & D, M. F. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00013 · Cited by 112
Use of cognitive therapy for relapse prevention in chronic depression: Cost-effectiveness study
Scott, J. L., Palmer, S., Paykel, E. S., Teasdale, J., & Hayhurst, H. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.182.3.221 · Cited by 112
Cussac, D., Newman‐Tancredi, A., Pasteau, V., & Millan, M. J. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1025 · Cited by 112
Self-citationArias-Carrión, Ó., Verdugo‐Díaz, L., Feria‐Velasco, A., Millán‐Aldaco, D., Gutierrez, A. A., Hernández‐Cruz, A., & Drucker-Colín, R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20235 · Cited by 111
Duloxetine in the Long-Term Treatment of Major Depressive Disorder
Raskin, J., GOLDSTEIN, D. J., Mallinckrodt, C. H., & Ferguson, M. B. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1015 · Cited by 111
Krobert, K. A., & Levy, F. O. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704588 · Cited by 111
Antidepressant-like effect of agmatine and its possible mechanism
Li, Y. F., Gong, Z. H., Cao, J., Wang, H. L., Luo, Z. P., & Li, J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01735-7 · Cited by 111
Rush, C. R., Kollins, S. H., & Pazzaglia, P. J. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.6.1.32 · Cited by 111
The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus
Ferraro, L., Antonelli, T., O'Connor, W. T., Tanganelli, S., Rambert, F. A., & Fuxé, K. (1997) · Neuroreport · doi:10.1097/00001756-199709080-00016 · Cited by 111
Raap, D. K., DonCarlos, L. L., García, F., Muma, N. A., Wolf, W. A., Battaglia, G., & de Kar, L. D. V. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00264-6 · Cited by 111
The Use of Trazodone as a Hypnotic: A Critical Review
JAMES, S. P., & Mendelson, W. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0605 · Cited by 111
Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative
Zhou, F., Lesch, K., & Murphy, D. L. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02709-9 · Cited by 111
Ainsworth, K., Smith, S. E., Zetterström, T., Pei, Q., Franklin, M., & Sharp, T. (1998) · Psychopharmacology · doi:10.1007/s002130050791 · Cited by 111
Yogev‐Falach, M., Amit, T., Bar‐Am, O., Weinstock, M., & Youdim, M. B. H. (2002) · The FASEB Journal · doi:10.1096/fj.02-0198fje · Cited by 110
Rojas-Corrales, M. O., Berrocoso, E., Gibert‐Rahola, J., & Micó, J. A. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02220-8 · Cited by 110
Neurochemical Mechanism of Action of Anorectic Drugs
SAMANIN, R., & Garattini, S. K. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01537.x · Cited by 110
Ruskin, D. N., Liu, C., Dunn, K. E., Bazan, N. G., & LaHoste, G. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03426.x · Cited by 110
Mills, R. H., Sohn, R. K., & Micevych, P. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1366-03.2004 · Cited by 110
Cholinergic-dopaminergic interactions in cognitive performance
Levin, E. D., McGurk, S. R., Rose, J. E., & Butcher, L. L. (1990) · Behavioral and Neural Biology · doi:10.1016/0163-1047(90)90639-n · Cited by 110
Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor
Heinrichs, S. C., Stenzel‐Poore, M. P., Gold, L. H., Battenberg, E. L. F., Bloom, F. E., Koob, G. F., Vale, W., & Pich, E. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00140-6 · Cited by 110
Kennett, G. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90133-3 · Cited by 110
Function of cGMP-dependent Protein Kinases in the Nervous System
Feil, R., Hofmann, F. B., & Kleppisch, T. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.1.23 · Cited by 110
Cardiovascular effects of antidepressant drugs: updated.
Glassman, A. H. (1998) · PubMed · Cited by 110
Molecular domestication – more than a sporadic episode in evolution
Miller, W. J., McDonald, J. F., Nouaud, D., & Anxolabéhère, D. (1999) · Genetica · doi:10.1023/a:1004070603792 · Cited by 110
The Pharmacologic Management of SSRI-Induced Side Effects: A Survey of Psychiatrists
Dording, C., Mischoulon, D., Petersen, T., Kornbluh, R., Gordon, J., Nierenberg, A., Rosenbaum, J., & Fava, M. (2002) · Annals of Clinical Psychiatry · doi:10.3109/10401230209147450 · Cited by 109
Localization of 5-ht5A receptor-like immunoreactivity in the rat brain
Oliver, K. R., Kinsey, A. M., Wainwright, A., & SIRINATHSINGHJI, D. J. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02273-3 · Cited by 109
Contreras, J., Parrot, I., Sippl, W., Rival, Y. M., & Wermuth, C. G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001088u · Cited by 109
Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites
Hamik, A., Oksenberg, D., Fischette, C. T., & Peroutka, S. J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90627-e · Cited by 109
Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats
Pietraszek, M., Sukhanov, I., Maciejak, P., Szyndler, J., Gravius, A., Wisłowska, A., Płaźnik, A., Bespalov, A., & Danysz, W. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.03.028 · Cited by 109
Pavlides, C., & McEwen, B. S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02188-5 · Cited by 109
MKenna, M. T., Proctor, G. R., Young, L., & Harvey, A. L. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970150t · Cited by 109
Introduction to the reviews on neuropeptide Y
Gehlert, D. R. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.07.002 · Cited by 109
Redrobe, J. P., Dumont, Y., Herzog, H., & Quirion, R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:3:159 · Cited by 109
Lieberman, J. A., Greenhouse, J. B., Hamer, R. M., Krishnan, K. R. R., Nemeroff, C. B., Sheehan, D. V., Thase, M. E., & Keller, M. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300571 · Cited by 109
Larisch, R., Klimke, A., Vosberg, H., Löffler, S., Gäebel, W., & Müller-Gärtner, H.-W. (1997) · NeuroImage · doi:10.1006/nimg.1997.0267 · Cited by 109
Gründemann, D., Hahne, C., Berkels, R., & Schömig, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044404 · Cited by 109
Russ, H., Staudt, K., Martel, F., Gliese, M., & Schömig, E. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01294.x · Cited by 109
Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation
Vialou, V., Amphoux, A., Zwart, R., Giros, B., & Gautron, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5147-03.2004 · Cited by 109
Ferreri, M., Lavergne, F., Berlin, I., Payan, C., & Puech, A. J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2001.00148.x · Cited by 108
Budziszewska, B., Jaworska-Feil, L., Kajta, M., & Lasoń, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703445 · Cited by 108
Structural plasticity and tianeptine: cellular and molecular targets
McEwen, B. S., Magarinos, A. M., & Reagan, L. P. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00650-8 · Cited by 108
Browning, D. D., McShane, M. P., Marty, C., & Ye, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2811 · Cited by 108
Dremencov, E., Gispan-Herman, I., Rosenstein, M., Mendelman, A., Overstreet, D. H., Zohar, J., & Yadid, G. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.030 · Cited by 108
Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function
Smith, G. S., Lotrich, F. E., Malhotra, A. K., Lee, A. T., Ma, Y., Kramer, E., Gregersen, P. K., Eidelberg, D., & Pollock, B. G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300552 · Cited by 108
Kawahara, Y., Kawahara, H., & Westerink, B. H. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01062-8 · Cited by 108
Just, H., Sitte, H. H., Schmid, J. A., Freissmuth, M., & Kudlacek, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306092200 · Cited by 108
Matsumoto, M., Togashi, H., Mori, K., Ueno, K.-I., Ohashi, S., Kojima, T., & Yoshioka, M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38802-0 · Cited by 108
Wilson, K., & Mottram, P. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1156 · Cited by 107
Molecular domestication — more than a sporadic episode in evolution
Miller, W. J., McDonald, J. F., Nouaud, D., & Anxolabéhère, D. (2000) · Springer eBooks · doi:10.1007/978-94-011-4156-7_22 · Cited by 107
Schreiber, S., Bleich, A., & Pick, C. G. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:143 · Cited by 107
Adamantidis, A., Thomas, E., Foidart, A., Tyhon, A., Coumans, B., Minet, A., Tirelli, E., Seutin, V., Grisar, T. M., & Lakaye, B. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04100.x · Cited by 107
Lamotrigine as Adjunct to Paroxetine in Acute Depression
Normann, C., Hummel, B., Schärer, L. O., Horn, M., Grunze, H., & Walden, J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0411 · Cited by 107
Czyrak, A., Czepiel, K., Maćkowiak, M., Chocyk, A., & Wędzony, K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03352-3 · Cited by 107
A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder
Liebowitz, M. R., Mangano, R. M., Bradwejn, J., & Asnis, G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0213 · Cited by 107
Ferraro, L., Tanganelli, S., O'Connor, W. T., Antonelli, T., Rambert, F. A., & Fuxé, K. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13212-2 · Cited by 107
Self-administration of cocaine analogs by rats
Roberts, D. C. S., Phelan, R., Hodges, L. M., Hodges, M. M., Bennett, B. A., Childers, S. R., & Davies, H. M. L. (1999) · Psychopharmacology · doi:10.1007/s002130051022 · Cited by 107
Barrett, J., Della‐Maggiore, V., Chouinard, P. A., & Paus, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300411 · Cited by 107
Roy, M., David, N. K., Danao, J., Baribault, H., Tian, H., & Giorgetti, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300805 · Cited by 107
Neuropeptides and male sexual behavior
Dornan, W. A., & Malsbury, C. W. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80046-6 · Cited by 107
Joyce, P. R., Mulder, R., Luty, S. E., McKenzie, J. M., Miller, A. L., Rogers, G. R., & Kennedy, M. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003663 · Cited by 107
Gene duplication and the origin of novel proteins
Hughes, A. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503922102 · Cited by 107
Origin and evolution of new exons in rodents
Wang, W., Zheng, H., Yang, S., Yu, H., Li, J., Jiang, H., Su, J., Yang, L., Zhang, J., McDermott, J., et al. (2005) · Genome Research · doi:10.1101/gr.3929705 · Cited by 107
Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition
Buccafusco, J. J., & Terry, A. V. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38924-4 · Cited by 107
Dremencov, E., Newman, M. E., Kinor, N., Blatman‐Jan, G., Schindler, C. J., Overstreet, D. H., & Yadid, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.013 · Cited by 107
Zanardi, R., Franchini, L., Gasperini, M., Lucca, A., Smeraldi, E., & Pérez, J. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00004 · Cited by 107
Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.
Hollander, E., & McCarley, A. (1992) · PubMed · Cited by 107
Modulation of synaptic transmission in neocortex by network activities
Crochet, S., Chauvette, S., Boucetta, S., & Timofeev, I. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03932.x · Cited by 106
Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors
Li, X., Witkin, J. M., Need, A. B., & Skolnick, P. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1023648923447 · Cited by 106
Independent Origins of Middle Ear Bones in Monotremes and Therians
Rich, T. H., Hopson, J. A., Musser, A. M., Flannery, T. F., & Vickers-Rich, P. (2005) · Science · doi:10.1126/science.1105717 · Cited by 106
Catecholamine transport by the organic cation transporter type 1 (OCT1)
Breidert, T., Spitzenberger, F., Gründemann, D., & Schömig, E. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702065 · Cited by 106
HPA axis activation in major depression and response to fluoxetine: a pilot study
Young, E. A., Altemus, M. M., López, J. F., Kocsis, J. H., Schatzberg, A. F., DeBattista, C., & Zubieta, J. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.02.002 · Cited by 106
Micevych, P. E., Matt, D. W., & Go, V. L. W. (1988) · Experimental Neurology · doi:10.1016/0014-4886(88)90119-7 · Cited by 106
van Staveren, W. C. G., Ittersum, M. M., Steinbusch, H. W. M., & de Vente, J. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03081-x · Cited by 106
Neumeister, A., Young, T. A., & Stastny, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1950-3 · Cited by 106
Heinrichs, S. C., Min, H., Tamraz, S., Carmouché, M., Boehme, S. A., & Vale, W. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00030-9 · Cited by 106
Millan, M. J., Seguin, L., Gobert, A., Cussac, D., & Brocco, M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1770-x · Cited by 106
Self-citationSchmitt, A., Mössner, R., Gossmann, A., Fischer, I., Gorboulev, V., Murphy, D., Koepsell, H., & Lesch, K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10521 · Cited by 106
Park, S. U., Ferrer, J. V., Javitch, J. A., & Kuhn, D. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04399.2002 · Cited by 106
Regulation of the serotonin transporter by interacting proteins
Haase, J. K., Killian, A.-M., Magnani, F., & Williams, D. C. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290722 · Cited by 106
Acute behavioral and physiological effects of modafinil in drug abusers
Rush, C. R., Kelly, T. H., Hays, L. R., Baker, R. W., & Wooten, A. F. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200203000-00002 · Cited by 106
Zarate, C. A., Quiroz, J. A., Quiroz, J. A., Manji, H. K., Payne, J. L., Kornstein, S. G., Manji, A. H. K., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4204 · Cited by 105
Sexual Behavior in Male Rats After Radiofrequency or Dopamine-Depleting Lesions in Nucleus Accumbens
Liu, Y., Sachs, B. D., & Salamone, J. D. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00022-7 · Cited by 105
Wood, M. D., Reavill, C., Trail, B. K., Wilson, A. W., Stean, T. O., Kennett, G. A., Lightowler, S., Blackburn, T. P., Thomas, D. W., Gager, T., et al. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00054-5 · Cited by 105
Shorter, E., & Tyrer, P. (2003) · BMJ · doi:10.1136/bmj.327.7407.158 · Cited by 105
The fallacy of behavioral phenotyping without standardisation
van der Staay, F. J., & Steckler, T. (2002) · Genes Brain & Behavior · doi:10.1046/j.1601-1848.2001.00007.x · Cited by 105
Glucocorticoids and neuroendocrine function
Cavagnini, F., Croci, M., Putignano, P., Petroni, M. L., & Invitti, C. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801284 · Cited by 105
Shimura, T., Yamamoto, T., & Shimokochi, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91875-9 · Cited by 105
Ziegler, D. R., Cullinan, W. E., & Herman, J. P. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20445 · Cited by 105
Genotype–environment interactions in mouse behavior: A way out of the problem
Kafkafi, N., Benjamini, Y., Sakov, A., Elmer, G. I., & Golani, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409554102 · Cited by 105
Effects of sertraline on autonomic and cognitive functions in healthy volunteers
Siepmann, M., Grossmann, J., M�ck-Weymann, M., & Kirch, W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1448-4 · Cited by 105
Kiss, J., Zsilla, G., & Vizi, E. S. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.004 · Cited by 105
Estrogen Augmentation of Antidepressants in Perimenopausal Depression: A Pilot Study
Morgan, M. L., Cook, I. A., Rapkin, A. J., & Leuchter, A. F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0617 · Cited by 104
Murphy, B. E. P., Filipini, D., & GHADIRIAN, A. M. (1993) · PubMed · Cited by 104
Low Levels of Transthyretin in the CSF of Depressed Patients
Sullivan, G. M., Hatterer, J. A., Herbert, J., Chen, X., Roose, S. P., Attia, E., Mann, J. J., Marangell, L. B., Goetz, R. R., & Gorman, J. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.710 · Cited by 104
GABAB Receptors: From Monogamy to Promiscuity
Calver, A. R., Davies, C. H., & Pangalos, M. N. (2002) · Neurosignals · doi:10.1159/000068257 · Cited by 104
AVP V selective antagonist SSR149415 blocks aggressive behaviors in hamsters
Blanchard, R. J., Griebel, G., Farrokhi, C. B., Markham, C. M., YANG, M., & Blanchard, D. C. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.024 · Cited by 104
Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex
López-Ávila, A., Coffeen, U., Ortega-Legaspi, M. J., del Ángel, R., & Pellicer, F. (2004) · Pain · doi:10.1016/j.pain.2004.06.010 · Cited by 104
Serotonin and substance P co-exist in dorsal raphe neurons of the human brain
Sergeyev, V., Hökfelt, T. G. M., & Hurd, Y. L. (1999) · Neuroreport · doi:10.1097/00001756-199912160-00044 · Cited by 104
Corrigan, M. H. N., Gallen, C. C., Bonura, M. L., & Merchant, K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.004 · Cited by 104
Seibyl, J. P., Krystal, J. H., Price, L. H., Woods, S. W., D'Amico, C., Heninger, G. R., & Charney, D. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90013-f · Cited by 104
Decreased histamine H1 receptor binding in the brain of depressed patients
Kano, M., Fukudo, S., Tashiro, A., Utsumi, A., Tamura, D., Itoh, M., Iwata, R., Tashiro, M., Mochizuki, H., Funaki, Y., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03540.x · Cited by 104
Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism
Paladini, C. A., Robinson, S., Morikawa, H., Williams, J. T., & Palmiter, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0138018100 · Cited by 104
Recent Advances in Melatonin Receptor Ligands
Zlotos, D. P. (2005) · Archiv der Pharmazie · doi:10.1002/ardp.200400996 · Cited by 104
Depression in Parkinson's disease
Allain, H. (2000) · BMJ · doi:10.1136/bmj.320.7245.1287 · Cited by 104
Growth Hormone, Insulin-Like Growth Factor-I and the Cortisol-Cortisone Shuttle
Stewart, P. M., Toogood, A. A., & Tomlinson, J. W. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048126 · Cited by 103
The Extraneuronal Uptake and Metabolism of Catecholamines
TRENDELENBURG, U. (1988) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-46625-0_6 · Cited by 103
Update on the Biology of Seasonal Affective Disorder
Sohn, C., & Lam, R. W. M. (2005) · CNS Spectrums · doi:10.1017/s109285290001960x · Cited by 103
Gobert, A., Rivet, J., Cistarelli, L., Melon, C., & Millan, M. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00211-0 · Cited by 103
Self-citationAmantadine as augmentation therapy in the management of treatment-resistant depression
Stryjer, R., Strous, R. D., Shaked, G., Bar, F., Feldman, B., Kotler, M., Polak, L., Rosenzcwaig, S., & Weizman, A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00005 · Cited by 103
Kondrashov, F. A., & Koonin, E. V. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(02)00029-x · Cited by 103
Subcellular distribution of 5‐HT1b and 5‐HT7 receptors in the mouse suprachiasmatic nucleus
Belenky, M. A., & Pickard, G. E. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1109 · Cited by 103
The gabaergic hypothesis of depression
Lloyd, K. G., Živković, B., Scatton, B., Morselli, P. L., & Bartholimi, G. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90123-1 · Cited by 103
Renard, C. E., Fiocco, A. J., Clénet, F., Hascoët, M., & Bourin, M. (2001) · Psychopharmacology · doi:10.1007/s002130100836 · Cited by 103
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.